Exploring the connection between gut bacteria and brain tumors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates how the gut microbiome may influence the growth and progression of malignant brain tumors. It aims to establish a biorepository at Mayo Clinic Florida by collecting various biological samples, including fecal, urine, blood, saliva, and tissue, from patients undergoing tumor resection. The study will utilize advanced techniques such as spatial transcriptomics and multi-omics to analyze the relationship between gut microorganisms and clinical outcomes in brain cancer patients. Participants will also complete questionnaires to provide additional clinical information.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All patients undergoing resection for a tumor of the central nervous system and associated controls are eligible to participate in this study.

Exclusion Criteria:

* Excluded samples will be from patients younger than 18 years old. There are no exclusions due to race/sex.

Where it's running

• Mayo Clinic in Florida
  Jacksonville, Florida, United States Recruiting

Study contacts

• Principal investigator: Alfredo Quinones-Hinojosa, M.D. — Mayo Clinic
• Study coordinator: Clinical Trials Referral Office
• Email: mayocliniccancerstudies@mayo.edu
• Phone: 855-776-0015

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Collecting data on side effects of proton therapy for cancer treatment

  This study is trying to learn about the side effects that cancer patients experience after receiving proton therapy to help improve future treatments.

  Recruiting M.D. Anderson Cancer Center · Houston, Texas · NCT00991094

• CBL0137 treatment for relapsed or refractory solid tumors and CNS tumors

  This study is testing a new treatment called CBL0137 to see if it can help children and young adults with tough-to-treat solid tumors and brain tumors feel better.

  Recruiting at 33 sites Phase 1/2 Children's Oncology Group · Birmingham, Alabama and 34 other locations · NCT04870944

• Avapritinib for treating advanced solid tumors with specific mutations

  This study is testing if a new drug called avapritinib can help people with advanced solid tumors that have specific mutations feel better and live longer after other treatments haven't worked.

  Recruiting Phase 2 M.D. Anderson Cancer Center · Houston, Texas · NCT04771520

• At-home cancer treatment versus clinic-based treatment for advanced cancer patients

  This study tests whether giving cancer treatment at home is better for comfort and satisfaction compared to getting it at a clinic for people with advanced cancer.

  Recruiting at 2 sites Phase 2 Mayo Clinic · Jacksonville, Florida and 1 other locations · NCT05969860

• Using ONC206 to treat newly diagnosed and recurrent brain tumors in children and young adults

  This study is testing a new treatment called ONC206, alone or with radiation, to see if it can help children and young adults with newly diagnosed or recurring brain tumors feel better.

  Recruiting at 7 sites Phase 1 University of California, San Francisco · San Francisco, California and 6 other locations · NCT04732065

• Using a virus therapy to treat recurrent cerebellar brain tumors in children

  This study is testing a new virus treatment for children with recurring brain tumors to see if it can help them get better when combined with a low dose of radiation.

  Recruiting at 3 sites Phase 1 M.D. Anderson Cancer Center · Birmingham, Alabama and 2 other locations · NCT03911388

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.